UP

Moderna Covid vaccine has 94% efficac

Home page World
12 Punto 14 Punto 16 Punto 18 Punto

Final results from the trials of Moderna’s vaccine against Covid-19 confirm it has 94% efficacy and nobody who was vaccinated with it developed the severe disease, says the company, kickstarting the approval process with regulators around the world.

Axar.az reports that the US company is submitting the data to the regulators in the US, Europe, and the UK for an emergency license. It expects the Food and Drug Administration in the US to consider it at its meeting on 17 December, Moderna said.

The UK has bought 7m doses of the vaccine – 5m on the day Moderna announced its interim result of 94.5% efficacy and a further 2m last week. But supplies of the vaccine to the UK are not expected until March. Moderna, based in Massachusetts, has received $2.48bn in US federal funds and was a key part of the Trump administration's Operation Warp Speed.

Date
2020.11.30 / 20:32
Author
Axar.az
Comments
See also

I suffer from depression - Musk

Stoltenberg visited Armenia

Weapons and ammunition were discovered in Khankendi

We can't wait, Ukraine needs ammunition - Pavel

The death of the Shadow Man has been confirmed

Turks are building NATO's biggest base in Europe

Armenia refused the Russian Mir

A law on LGBT is being prepared in Georgia

There was a strong earthquake in Pakistan

NATO has been deceiving for 15 years

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla